abstract |
The invention relates to compounds that bind to the NR1H4 receptor (FRX) and act as NR1H4 receptor agonists (FRX). The invention also relates to the use of compounds for the preparation of a medicament for the treatment of diseases and / or conditions due to the binding of said nuclear receptor with said compounds, as well as to a method for synthesizing these compounds. |